Venous Thromboembolism - Epidemiology - Middle East & Africa
Diagnosed Incidence of Venous Thromboembolism Among People of All Ages in 2021 and 2031
Relative Sizes of Factors Contributing to the Trend in Diagnosed Incidence of Venous Thromboembolism Over the Next 10 Years
Analysis of the Diagnosed Venous Thromboembolism Events by Etiology
Diagnosed Events of Venous Thromboembolism
Venous Thromboembolism Events by Etiology
Venous Thromboembolism Events by Cancer Association
Venous Thromboembolism Events by Recurrence
Studies Included in the Analysis of Venous Thromboembolism
Studies Excluded from the Analysis of Venous Thromboembolism
Risk/Protective Factors for Venous Thromboembolism
Sunali D. Goonesekera, S.M.
Sunali Goonesekera, S.M., is a senior epidemiologist at Clarivate. Previously, Ms. Goonesekera conducted epidemiological research on racial/ethnic disparities in metabolic diseases at the New England Research Institute and lead-authored two manuscripts. She has contributed to multiple publications in peer-reviewed journals in epidemiology and the biological sciences. She holds a master’s degree in epidemiology from the Harvard School of Public Health and a B.A. in biology (Honors) from Dartmouth College.
Emma McFadden, Ph.D.
Emma McFadden, Ph.D., is a director on the CNS/Ophthalmology Disorders team at Clarivate. Her focus is on ophthalmic indications, such as age-related macular degeneration, diabetic retinopathy, and diabetic macular edema, although she has authored reports in a number of other indications, including multiple sclerosis and epilepsy. Dr. McFadden earned a B.A. in neuroscience and a Ph.D. in biochemistry from Trinity College in Dublin.